{
    "SPADE_N_14334": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14334",
            "Peptide Name": "EntV-derived P4 (Synthetic AMPs)",
            "Source": "bacteria-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "VQLALWAVQC",
            "Sequence Length": 10,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antifungal",
                "Antifungal",
                "Antibiofilm"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1130.36,
            "PI": 5.49,
            "Hydrophobicity": 1.42,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Guha S, Cristy SA, Buda De Cesare G, Cruz MR, Lorenz MC, Garsin DA. 2024",
                    "Reference": "mBio. 2024 May 8;15(5):e0057024. doi: 10.1128/mbio.00570-24.PubMed",
                    "Title": "Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis."
                }
            ],
            "Frequent Amino Acids": "ALQ",
            "Absent Amino Acids": "DEFGHIKMNOPRSTUY",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 7,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "Net Charge": 0,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (90%) toEntV 10merV=L=A=Q: 20%, others: 10%.Activity: active against C. albicans and C. gattii based on the survival of the infected animal model:Caenorhabditis elegans.  P4 appeared to be better than other Px peptides in the series in protecting the animals from C. gattii infection.Animal model:mouse: Like its parent peptide EntV, P1 protected mice from C. albicans systemic infection.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_10861",
                    "Similarity": 1.0,
                    "Sequence": "GIDAVLSMETQNIQEPQLGAGTYVQL"
                },
                {
                    "SPADE_ID": "SPADE_UN_18259",
                    "Similarity": 1.0,
                    "Sequence": "TENRYCVQL"
                },
                {
                    "SPADE_ID": "SPADE_UN_18438",
                    "Similarity": 1.0,
                    "Sequence": "YTFSGDVQL"
                }
            ]
        }
    }
}